Narrow Ruling in Bilski Case Maintains Patentability of Diagnostics, other Biotech Inventions
June 28, 2010
Narrow Ruling in Bilski Case Maintains Patentability of Diagnostics, other Biotech Inventions
The decision ultimately upholds the patent eligibility of certain innovations not tied to a physical instrument, such as software, data-driven processes, and medical diagnostics.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Federal Circuit Judges Considered USPTO Policy, Industry Impact in Ruling on Myriad's Gene Patents
August 22, 2012 / Pharmacogenomics Reporter - Appeals Court Affirms Isolated DNA Patents in Myriad Case
August 16, 2012 / GenomeWeb Daily News - USPTO Hearing on Confirmatory Gene Testing Raises Calls for Reform Outside Patent System
February 22, 2012 / Pharmacogenomics Reporter - ACLU, PUBPAT Seek to Challenge Patentability of Isolated Genes Before Supreme Court
October 12, 2011 / Pharmacogenomics Reporter - UMich Center to Offer Clinical Next-Gen Sequencing of Cancer Patients
August 31, 2011 / Clinical Sequencing News